Test Price
800 AED✅ Home Collection Available
Beta Thalassemia Prenatal Screening in UAE | 800 AED | DHA Guidelines
Executive Summary & Core Metrics
- Diagnostic Accuracy: >99% sensitivity and specificity via ISO-accredited End-Point PCR methodology.
- Sampling Logistics: Hospital extraction only – sample collection conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Medical Guidance: Post-test telephonic consultation for result interpretation and genetic counseling referral.
- Insurance Support: Direct verification via WhatsApp +971545488731.
Test Overview & Methodology
Beta Thalassemia Prenatal Screening detects fetal beta globin gene mutations using End-Point PCR, delivering >99% diagnostic accuracy for informed prenatal decision‑making. This DNA-based analysis enables precise carrier and disease status determination from invasive fetal samples.
| Feature | Our Beta Thalassemia Prenatal Screening | Standard HPLC Electrophoresis |
|---|---|---|
| Methodology | End‑Point PCR (DNA‑based) | Hb Electrophoresis / HPLC |
| Diagnostic Precision | >99% sensitivity & specificity | ~95% carrier detection rate |
| Turnaround Time | 3–4 working days | 5–7 days |
| Sample Type | Amniotic fluid, chorionic villi, umbilical cord blood | Maternal blood only |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh | Consultant Medical Genetics (DHA Registration ID: 9294403): “Beta thalassemia prenatal screening is a cornerstone of genomic prenatal care. Detection of beta globin mutations empowers families with evidence-based reproductive options. All results must be interpreted alongside fetal ultrasound and genetic counseling. Never base clinical decisions solely on this screening.”
Medication Advisory
Do not discontinue prescribed anticoagulant or antiplatelet medications without consulting your obstetrician. These may need adjustment before invasive sampling to minimize bleeding risk.
Safety Exclusion Criteria & Emergency Red Flags
- Active vaginal bleeding or ruptured membranes – contraindicates invasive sampling
- Signs of preterm labor or cervical insufficiency
- Fever >38°C or clinical evidence of intra‑amniotic infection
- Seek immediate emergency care if you experience severe abdominal cramping, heavy bleeding, or fever after the procedure.
Patient FAQ & Clinical Guidance
1. What does the Beta Thalassemia Prenatal Screening detect?
A: Beta thalassemia prenatal screening uses End‑Point PCR to detect fetal beta globin gene mutations for accurate carrier or disease diagnosis. It distinguishes between carriers, affected fetuses, and unaffected individuals.
2. How is the sample collected for prenatal thalassemia screening?
A: A DHA‑licensed obstetrician obtains amniotic fluid or chorionic villi under ultrasound guidance. This is a minimally invasive outpatient procedure with a low complication rate. The collected specimen is immediately stabilized and transported under cold chain to our laboratory.
3. Is the 800 AED price inclusive of all services?
A: The 800 AED package includes hospital‑grade extraction, temperature‑controlled transport, End‑Point PCR analysis, and a post‑test telephonic clinical guidance session for result interpretation and genetic counseling referral. Insurance verification is available via WhatsApp.
UAE Regulatory & Data Privacy Adherence
This test operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted and handled with strict confidentiality. DHA Facility License: 1143. Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Laboratory: DNA Labs UAE.
Clinical & Logistical Metadata
| Test Name | Beta Thalassemia Prenatal Screening |
| Price (AED) | 800 (including hospital extraction, cold-chain transport and post-test consultation) |
| Turnaround Time | 3–4 working days from sample receipt |
| Sample Type / Matrix | Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. Specimens: Amniotic fluid, chorionic villi, umbilical cord blood. |
| Methodology Used | End‑Point PCR (DNA‑based) |
| ICD-10-CM Code | D56.1 (Beta thalassemia) |
| LOINC Code | 53926-4 (Beta globin gene mutation analysis) |
| DHA Facility License & Address | License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians